All News about Virios Therapeutics Inc
Benzinga's Top Ratings Upgrades, Downgrades For September 20, 2022
September 20, 2022
Via Benzinga
Virios Therapeutics Shares Tank After Failing Fibromyalgia Study
September 19, 2022
Via Benzinga
Virios Therapeutics, Inc. Announces Pricing of Public Offering
September 19, 2022
Via Business Wire
Virios Therapeutics, Inc. Announces Proposed Public Offering
September 19, 2022
Via Business Wire
Stocks That Hit 52-Week Lows On Monday
September 19, 2022
Via Benzinga
Recap Of Monday's Biotech Catalysts - End Of the Day Summary
August 15, 2022
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|